(R)-2-(1-Aminoethyl)-N-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)thiazole-5-carboxamide
- CAS
- 1095823-62-3
- Formula
- C12H10ClF3N4OS
- MW
- 350.75 g/mol
VQ-028471
Impurity reference standards
Tovorafenib impurities & reference standards
Characterised Tovorafenib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
12reference materials
COAHPLC · NMR · MS on request
Parent API: Tovorafenib
1096708-71-2 · C17H12Cl2F3N7O2S
3,5-Dichloro-4-(trifluoromethyl)-2-pyridinamine
- CAS
- 1446182-76-8
- Formula
- C6H3Cl2F3N2
- MW
- 231 g/mol
VQ-042631
5-Chloro-1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acid
- CAS
- 914916-96-4
- Formula
- C5H3ClN2O3
- MW
- 174.54 g/mol
VQ-042632
FAQs — Tovorafenib impurities
Which Tovorafenib impurities do you supply?
We list 12 Tovorafenib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Tovorafenib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Tovorafenib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Tovorafenib impurity standards
We reply within one business day with price, pack options, lead time and documentation.